Lynch H - Search Results

1

Increasing incidence of breast cancer in family with BRCA1 mutation.

Narod S, Lynch H, Conway T, Watson P, Feunteun J, Lenoir G. Narod S, et al. Among authors: lynch h. Lancet. 1993 Apr 24;341(8852):1101-2. doi: 10.1016/0140-6736(93)92468-9. Lancet. 1993. PMID: 8097005 No abstract available.

2

Histology of BRCA1-associated ovarian tumours.

Narod S, Tonin P, Lynch H, Watson P, Feunteun J, Lenoir G. Narod S, et al. Among authors: lynch h. Lancet. 1994 Jan 22;343(8891):236. doi: 10.1016/s0140-6736(94)91021-9. Lancet. 1994. PMID: 7904689 No abstract available.

3

In-situ breast cancer and BRCA1.

Sun CC, Lenoir G, Lynch H, Narod SA. Sun CC, et al. Among authors: lynch h. Lancet. 1996 Aug 10;348(9024):408. doi: 10.1016/s0140-6736(05)65027-1. Lancet. 1996. PMID: 8709756 No abstract available.

4

The gene for hereditary breast-ovarian cancer, BRCA1, maps distal to EDH17B2 in chromosome region 17q12-q21.

Tonin P, Serova O, Simard J, Lenoir G, Feunteun J, Morgan K, Lynch H, Narod S. Tonin P, et al. Among authors: lynch h. Hum Mol Genet. 1994 Sep;3(9):1679-82. doi: 10.1093/hmg/3.9.1679. Hum Mol Genet. 1994. PMID: 7833928

5

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.

Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H; Hereditary Breast Cancer Clinical Study Group. Narod SA, et al. Among authors: lynch h. Lancet. 2000 Dec 2;356(9245):1876-81. doi: 10.1016/s0140-6736(00)03258-x. Lancet. 2000. PMID: 11130383

6

Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.

Narod SA, Sun P, Ghadirian P, Lynch H, Isaacs C, Garber J, Weber B, Karlan B, Fishman D, Rosen B, Tung N, Neuhausen SL. Narod SA, et al. Among authors: lynch h. Lancet. 2001 May 12;357(9267):1467-70. doi: 10.1016/s0140-6736(00)04642-0. Lancet. 2001. PMID: 11377596

7

CHEK2 mutation and hereditary breast cancer.

Narod SA, Lynch HT. Narod SA, et al. J Clin Oncol. 2007 Jan 1;25(1):6-7. doi: 10.1200/JCO.2006.08.8229. Epub 2006 Nov 28. J Clin Oncol. 2007. PMID: 17132696 No abstract available.

8

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.

Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H. Lerman C, et al. Among authors: lynch h, lynch j. JAMA. 1996 Jun 26;275(24):1885-92. JAMA. 1996. PMID: 8648868

9

Risk modifiers in carriers of BRCA1 mutations.

Narod SA, Goldgar D, Cannon-Albright L, Weber B, Moslehi R, Ives E, Lenoir G, Lynch H. Narod SA, et al. Among authors: lynch h. Int J Cancer. 1995 Dec 20;64(6):394-8. doi: 10.1002/ijc.2910640608. Int J Cancer. 1995. PMID: 8550241

10

The human insulin-like growth factor-binding protein 4 gene maps to chromosome region 17q12-q21.1 and is close to the gene for hereditary breast-ovarian cancer.

Tonin P, Ehrenborg E, Lenoir G, Feunteun J, Lynch H, Morgan K, Zazzi H, Vivier A, Pollak M, Huynh H, et al. Tonin P, et al. Among authors: lynch h. Genomics. 1993 Nov;18(2):414-7. doi: 10.1006/geno.1993.1487. Genomics. 1993. PMID: 7507078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,498 results

Search Page